Vicore sells rights to IPF drug in Japan; Roche to lay off 340 workers; Sensorion’s €50M offering
Plus, news about Tenaya Therapeutics, Adverum Biotechnologies, YS Biopharma, Evoke Pharma and BioXcel Therapeutics:
Nippon Shinyaku gets rights in Japan to IPF drug: The Japanese …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.